Spruce Street Capital LP
Source: SEC Form 13F · as of Mar 2026Spruce Street Capital LP holds 17 biotech & pharma companies tracked by BioSniper, totaling $288.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$288.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for RELMADA THERAPEUTICS, INC. (RLMD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| RLMDRELMADA THERAPEUTICS, INC. | 6,262,114 | $43.0M |
| KNSAKiniksa Pharmaceuticals International, plc | 761,063 | $36.6M |
| LBRXLB PHARMACEUTICALS INC | 1,376,159 | $33.6M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 373,274 | $31.3M |
| CNTACentessa Pharmaceuticals plc | 489,849 | $19.5M |
| SVRASavara Inc | 3,383,175 | $18.5M |
| KALVKalVista Pharmaceuticals, Inc. | 897,681 | $18.1M |
| PCVXVaxcyte, Inc. | 245,709 | $14.3M |
| ELVNEnliven Therapeutics, Inc. | 329,006 | $12.9M |
| SRZNSurrozen Inc. | 432,040 | $12.6M |
| CATXPerspective Therapeutics, Inc. | 2,627,107 | $11.0M |
| ALMSALUMIS INC. | 392,574 | $8.6M |
| SABSSAB BIOTHERAPEUTICS, INC. | 2,198,502 | $8.4M |
| MAZEMaze Therapeutics, Inc. | 200,000 | $6.0M |
| ANTXAN2 Therapeutics, Inc. | 1,661,073 | $5.6M |
| ALECAlector, Inc. | 2,101,068 | $4.5M |
| LONALeonaBio, Inc. | 393,701 | $3.8M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.